Roy Warren, CEO of Attitude Drinks, commented, “Our agreements with great beverage distribution companies like Brown with their superior reputation in customer service are the foundation of our sales opportunity in Walgreens and many other retail accounts in Florida.”

Jack Shea, Executive Vice President Sales, said: “We are delighted to be working with such a strong distributor as Brown Distributors in Florida. The recent authorization of Phase III® Recovery in Walgreens requires excellence in sales and distribution organization to the stores. Brown is a leader in the sales and distribution of non-alcoholic beverages.

About Attitude Drinks:

Attitude Drinks, Inc. is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III® is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. For more information, including recent clinical trial results, visit www.attitudedrinks.com.

This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

Contact:
Roy Warren, CEO
Attitude Drinks, Inc.
561.227.2727
roy@attitudedrinks.com
www.attitudedrinks.com

SOURCE Attitude Drinks, Inc.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MicroFluidic Systems, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

Statements about PositiveID’s future expectations, including forward looking statements in PositiveID’s interview with SmallCapVoice.com relating to its diabetes management products, molecular diagnostics and homeland defense products, and all other statements in this press release and PositiveID’s interview with SmallCapVoice.com other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete development of and commercialize its diabetes management product, molecular diagnostic systems products and homeland defense products; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Contact:

Allison Tomek
561-805-8000
atomek@positiveidcorp.com

Contact for SmallCapVoice.com:

Stuart T. Smith
512-267-2430
info@smallcapvoice.com

Source: SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

Viper Network shareholders and potential investors are encouraged to follow the Company’s progress closely and keep the symbol VPER on their watch list for more news announcements and press releases.

For additional information, please visit www.vipernetworks.com, www.LEDsAmerica.com and www.LEDOglobal.com.

Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from the results predicted and reported results should not be considered an indication of future performance.

Contact:
Heritage First Capital
Scott Gibson, 407-444-5959

Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
info@smallcapvoice.com

SOURCE SmallCapVoice.com, Inc.

DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.

Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure of blood glucose. The Easy Check technology is based on a patent-pending reagent cell that mixes a patient’s exhaled air with a proprietary chemical compound, triggering a chemical reaction. The reaction is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body. The goal of Easy Check is to eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading.

The purpose of the clinical study is to assess the feasibility of Easy Check compared to a standard invasive blood glucose meter and to assess the reliability of Easy Check in measuring blood glucose levels under conditions of altered blood glucose levels. The study will be led by principal investigator Moshe Phillip, Professor and Director of the Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel.

Prof. Phillip said, "We are eager to begin testing PositiveID’s Easy Check breath device with the hope that one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients."

PositiveID Chairman and CEO William J. Caragol, said, "After previously announcing positive preliminary laboratory results from testing Easy Check in 2011, this independent clinical study is an important milestone in the advancement of Easy Check. We are very pleased that Prof. Phillip, a world renowned endocrinologist heavily involved in groundbreaking diabetes research, is spearheading this study and we look forward to communicating our progress."

The clinical study has been approved as compliant with the Declaration of Helsinki, which is a set of ethical principles regarding human experimentation developed for the medical community by the World Medical Association.

More than 25 million children and adults in the U.S. have diabetes, or over 8 percent of the population, according to the 2011 National Diabetes Fact Sheet. The CDC predicts that nearly 30 percent of children born after the year 2000 will develop diabetes. The lifetime risk of developing diabetes for those born in the year 2000 is 35 percent. The total cost of diagnosed diabetes in the U.S. is estimated at $200 billion.

Schneider Children’s is the only comprehensive, highly specialized care hospital of its kind in the country of Israel and in the Middle East, dedicated exclusively to the well-being of all children and adolescents. Schneider Children’s provides the full range of pediatric subspecialties and comprehensive paramedical services to all children. The medical center serves as the national referral center for Hematology-Oncology, Endocrinology and Childhood Diabetes, and Cardiology and is the country’s leading institution in the field of bone marrow and organ transplants, such as heart and lung, liver and kidney.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

The PositiveID Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7717

Statements about PositiveID’s future expectations, including the likelihood that the Company expects to begin recruiting subjects for the Easy Check clinical trial this month; the likelihood that the reaction from exhaled breath is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body; the likelihood that Easy Check will eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading; the likelihood that, one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients; the likelihood that PositiveID will communicate its progress with this clinical trial; the likelihood that nearly 30 percent of children born after the year 2000 will develop diabetes; the likelihood that the lifetime risk of developing diabetes for those born in the year 2000 is 35 percent; the likelihood the total cost of diagnosed diabetes in the U.S. is estimated at $200 billion; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete this clinical trial of Easy Check; PositiveID’s ability to commercialize Easy Check; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

CONTACT: Allison Tomek
561-805-8000
atomek@positiveidcorp.com

Source: Globe Newswire (February 7, 2012 – 4:15 PM EST)

DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.

Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure of blood glucose. The Easy Check technology is based on a patent-pending reagent cell that mixes a patient’s exhaled air with a proprietary chemical compound, triggering a chemical reaction. The reaction is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body. The goal of Easy Check is to eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading.

The purpose of the clinical study is to assess the feasibility of Easy Check compared to a standard invasive blood glucose meter and to assess the reliability of Easy Check in measuring blood glucose levels under conditions of altered blood glucose levels. The study will be led by principal investigator Moshe Phillip, Professor and Director of the Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel.

Prof. Phillip said, “We are eager to begin testing PositiveID’s Easy Check breath device with the hope that one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients.”

PositiveID Chairman and CEO William J. Caragol, said, “After previously announcing positive preliminary laboratory results from testing Easy Check in 2011, this independent clinical study is an important milestone in the advancement of Easy Check. We are very pleased that Prof. Phillip, a world renowned endocrinologist heavily involved in groundbreaking diabetes research, is spearheading this study and we look forward to communicating our progress.”

The clinical study has been approved as compliant with the Declaration of Helsinki, which is a set of ethical principles regarding human experimentation developed for the medical community by the World Medical Association.

More than 25 million children and adults in the U.S. have diabetes, or over 8 percent of the population, according to the 2011 National Diabetes Fact Sheet. The CDC predicts that nearly 30 percent of children born after the year 2000 will develop diabetes. The lifetime risk of developing diabetes for those born in the year 2000 is 35 percent. The total cost of diagnosed diabetes in the U.S. is estimated at $200 billion.

Schneider Children’s is the only comprehensive, highly specialized care hospital of its kind in the country of Israel and in the Middle East, dedicated exclusively to the well-being of all children and adolescents. Schneider Children’s provides the full range of pediatric subspecialties and comprehensive paramedical services to all children. The medical center serves as the national referral center for Hematology-Oncology, Endocrinology and Childhood Diabetes, and Cardiology and is the country’s leading institution in the field of bone marrow and organ transplants, such as heart and lung, liver and kidney.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

The PositiveID Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7717

Statements about PositiveID’s future expectations, including the likelihood that the Company expects to begin recruiting subjects for the Easy Check clinical trial this month; the likelihood that the reaction from exhaled breath is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body; the likelihood that Easy Check will eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading; the likelihood that, one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients; the likelihood that PositiveID will communicate its progress with this clinical trial; the likelihood that nearly 30 percent of children born after the year 2000 will develop diabetes; the likelihood that the lifetime risk of developing diabetes for those born in the year 2000 is 35 percent; the likelihood the total cost of diagnosed diabetes in the U.S. is estimated at $200 billion; and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete this clinical trial of Easy Check; PositiveID’s ability to commercialize Easy Check; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

CONTACT: Allison Tomek
561-805-8000
atomek@positiveidcorp.com

HONG KONG, Feb. 6, 2012 /PRNewswire/ — Sino Payments, Inc. (OTCQB: SNPY) a technology Company providing proprietary IP transactions processing services to the retail industry, today announced that as a follow on to the recently announced merger with TAP Investments Group, a TAP wholly owned subsidiary in the People’s Republic of China (PRC) has signed a contract worth over USD1.5 Million with Wincor Nixdorf for the provision of Helpdesk, Hardware, Software Maintenance, New Store Opening and IMAC services to the world #1 Health & Beauty retailer’s 1100+ retail outlets in the PRC. The contract services started on the 1st of January 2012 and will last until 31stDecember 2012.

TAP Investment Group and Sino Payments have signed a merger agreement whereby all TAP activities including those for this new contract will be folded into Sino Payments (OTCQB: SNPY) effective as of merger close and consolidated financials expected to be as of March 2012. The merger process has not yet been completed but many of the related tasks have been and we expect to make additional related announcements as soon as possible.

Matthew Mecke, CEO of Sino Payments, Inc. proclaimed, “Our merger partner TAP has been profitable for the last 5 years from 2005 to 2010 with approx. 20% plus net margins on 4mln USD in Gross Revenue. This agreement announced today significantly increases the top line and bottom line numbers for TAP and is an indication of where this company is going post merger with TAP. We feel strongly that there is much more to come and we are very pleased to be making this announcement today and congratulate the team at TAP for this additional contract on top of what has been announced recently in terms of new business from existing clients and new deployment of mobile stored value card service to some existing TAP clients.”

Calinda Lee, General Manager of TAP Services (HK) Ltd. stated, “On top of the size of this order, which is more than 1/3 of our 2012 budget and solidifies our standing in the retail solution market in Asia, the fact that the end-user is opening on average 1 shop per day in the PRC makes this deal extra attractive to us and it also represents a good foundation to build and expand our Retail Alliance and mobile Stored Value Card initiative which is a virtual gift card and virtual loyalty type solution.”

About TAP (www.tap-group.com.cn)

TAP is a leading provider of customer-centric solutions for the retail industry. By integrating market-leading Point-of-Sales/Point-of-Interaction (POS/POI) and retail CRM solutions, TAP provides retailers with the capability to offer a consistent shopping experience across all channels, all the time, enabling them to easily and effectively manage the customer lifecycle on a one-to-one basis.

TAP is Headquartered in Hong Kong with offices in Macau, Shenzhen, Guangzhou, Shanghai, Beijing, and Manila with over 200 staff.

About Sino Payments, Inc. (www.sinopayments.com)

Sino Payments is a US public company with offices in Hong Kong. Sino Payments focuses on providing IP credit and debit card processing services to large retail chains, including supermarket chains and large regional multinational retailers, in China and throughout Asia. Sino Payments has agreed with TAP to merger TAP operations and financials into Sino Payments with an expected merger close and full consolidation as of March 2012.

About Wincor Nixdorf (www.wincor-nixdorf.com)

Wincor Nixdorf as the Global parent Company Group has a presence in about 100 countries, with its own subsidiary companies in 38 of these. A total of more than 9,000 employees work at Wincor-Nixdorf. Wincor-Nixdorf is the leader in Europe and the number 3 in the world for programmable electronic POS systems (EPOSs) and the number 2 in Europe and worldwide for automated teller machines. Wincor-Nixdorf has production facilities at Paderborn, Germany, and in Singapore, Shanghai and Sao Paolo.

Contacts:
Sino Payments, Inc.
Matthew Mecke
Chairman & CEO
T 1.877.205.6270 x801
ir@sinopayments.com

SOURCE Sino Payments, Inc.

Golden Krust, in Terminal A between Gates A20-28 and A30-39 prior to security, is among the busiest Golden Krust franchise locations. Marley Coffee is now being served to Golden Krust customers from branded brewers and dispensers in a bright and sunny Caribbean atmosphere created to give passengers the feel of the islands, while offering the authentic taste of the islands that Golden Krust is renowned for. Menu items include Jamaican beef patties and jerk chicken combinations, along with pastries such as coco bread and rum cake. Golden Krust is brewing four Marley Coffee varieties: Jamaica Blue Mountain, Lively Up! Espresso, Get Up, Stand Up Breakfast Blend, and Simmer Down Decaf.

“Golden Krust has brought the taste of the Caribbean to the US since 1989 and we’re excited to begin a relationship with them as we bring Marley Coffee to passengers traveling through one of the busiest airports in the nation at one of Golden Krust’s busiest locations,” said Brent Toevs, CEO, Marley Coffee.

“Being the first Caribbean food franchise in a major metropolitan airport, it was perfectly logical to complement our food with the iconic Marley Coffee brand,” said Lorna Romans, Golden Krust Franchise Owner. “The unique coffee aroma and the ambiance was designed to stimulate our customers with traditional home style cooking and taste that gives them the feeling of being back in the islands.”

Marley Coffee will also soon be served at the Golden Krust located at 476 Lyons Avenue in Newark, NJ as well as other locations.

“The origins of Golden Krust date back to the Hawthorne family bakery in St. Andrews, Jamaica, so this partnership really hits close to home for me,” said Rohan Marley, chairman and co-founder, Marley Coffee. “We hope to bring to people at Newark Airport a little oasis to escape the stress of their travels, while beginning a relationship with Golden Krust that we eagerly look to expand.”

Marley Coffee is available in the metropolitan New York region through a partnership with The Evans Company, a leading coffee, water and food services provider serving the area since 1960. For sales inquiries email the company at sales@marleycoffee.com or phone the company at (323) 556-0746.

Marley Coffee offers seven varieties of new Marley Coffee Organic Ground packed in 8oz. bags and featuring the iconic Marley Lion and image of Rohan Marley. Marley Coffee Organic Ground is certified USDA organic. Marley Coffee also offers a premium assortment of 12oz. Whole Bean Coffee as well as Single-Serve Pods for home, office and food service.

All Marley Coffee products live up to the Rastafari standards of ITAL, standing for all things Pure, True and Vital. A portion of all sales of Marley Coffee supports the Kicks for Cause Foundation. Started by Marley Coffee, Kicks for Cause aims to build playable soccer fields and soccer camps for children of coffee-producing communities in Jamaica.

Golden Krust Bakery & Grill, Inc., www.goldenkrustbakery.com , is a Caribbean food chain. Founded in 1989 by Lowell Hawthorne and his family, Golden Krust is headquartered in Bronx, NY and has 120 stores nationwide.

About Marley Coffee
Marley Coffee (corporate name Jammin Java Corp) is a US-based company that provides premium, artisan roasted coffee to the grocery, retail, online, service, hospitality, office coffee service and big box store industry. Under its exclusive licensing agreement with 56 Hope Road, the company continues to develop its coffee lines under the Marley Coffee brand. Marley Coffee is a fully reporting company quoted on the OTCBB under the symbol JAMN. Learn more at www.MarleyCoffee.com, visit the corporate website at www.JamminJavaCorp.com, join us on Facebook at http://www.facebook.com/MarleyCoffee, and follow us on Twitter at http://twitter.com/marleycoffee.

Learn more about other Marley Family ventures by visiting The House of Marley at www.thehouseofmarley.com, Marley Beverage Company at www.MarleyBeverages.com, and 1Love.org at www.1love.org.

For sales inquiries, please contact sales@marleycoffee.com or call the company at (323) 556-0746

For additional news about the company listen to the latest CEO interview at
http://smallcapvoice.com/blog/1-3-12-smallcapvoice-interview-with-marley-coffee-otcbb-jamn/.

Forward-Looking Statement:
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Acts”) . In particular, the words “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project,” “propose,” “plan,” “intend,” and similar conditional words and expressions are intended to identify forward-looking statements and are subject to the safe harbor created by these Acts. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. These risks and others are included from time to time in documents we file with the Securities and Exchange Commission (“SEC”), including but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on our future results. Accordingly, you should not place undue reliance on these forward-looking statements. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The Company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the Company. The Company’s SEC filings are available at http://www.sec.gov.

Media: Mike Rosen or Vanessa Giacoppo
516-767-9653
marleycoffee@bluewolfden.com

Investors: StuartT. Smith
512-267-2430
info@smallcapvoice.com

In regard to AmeriLithium’s four Nevada-based properties – Paymaster, Clayton Deep, Full Monty, and Jackson Wash – the Company has now received all reports associated with both the gravity and CSAMT surveys for each of the properties, thereby concluding the final phase of a two-phase geophysical exploration program. The purpose of the geophysical exploration program has been to identify geologic conditions favorable for lithium-bearing brine accumulation beneath the four Nevada claim blocks and to identify targets on each property for exploration drilling during the next phase of exploration. Planning and permitting for a targeted drilling program has begun. In particular, the new drill program will include further development of the first stage drilling that was completed on the Company’s Paymaster property on April 11, 2011, which included the successful drilling of the initial 3 holes of that property’s 8-hole drill program.

In regard to the completion of the Jackson Wash property CSAMT survey, findings from a previous gravity survey were used to place the CSAMT survey lines over the deepest central portion of the Jackson Wash basin. The stratigraphic and structural detail shown in the data for both survey lines is excellent and indicates the presence of highly conductive layers and geologic structures that are strong indicators of brines below the surface within the Jackson Wash claim block.

Zonge International completed the CSAMT survey in December 2010 over the central portion of the Jackson Wash property. A detailed interpretive report on the methodology and results of the CSAMT survey has been received from J.L. Wright Geophysics. Wright compiled and interpreted the data collected by Zonge with the objective of defining structures and stratigraphy in the basin that resemble the deposit model for lithium brine deposits in nearby Clayton Valley. As an aid to the development of a lithium brine test drilling program, Wright has identified and described geologic conditions similar to the Clayton Valley deposit model.

Sedimentary units are evident in the interpreted data along both survey lines. Distinct low-resistivity layers stand out on both survey profiles as separate from high-resistivity beds above and below. Of significance is the presence of a low-resistivity layer approximately 250 to 400 meters thick lying between 500 and 750 meters below the surface. In addition, a 200-meter thick high-conductance layer is present at a shallower depth (350 meters) in the center of the basin. These are similar geologic conditions to those in which lithium has accumulated in Clayton Valley and from which Chemetall-Foote has been producing lithium. According to Chemetall reports, the presence of highly conductive (low resistivity) sedimentary units in proximity to basin-bounding and inter-basin faults is an important indicator of the presence of brines in Clayton Valley.

While the presence of low resistivity in sedimentary layers within the Jackson Wash Basin and their proximity to inter-basin faults is highly suggestive of brine aquifers, it does not guarantee the presence of economic lithium-bearing brine concentrations. Rather, the only true test for economic concentrations of lithium is drilling, groundwater sampling, and laboratory analysis, which comprise the next step in the Company’s exploration process.

Four drillhole locations have been identified based on the CSAMT results. Drilling depths are anticipated to be between 275 and 845 meters. Drillholes will be designed to penetrate into the low-resistivity units and collect water samples for analysis. An additional target will be the base of the conductive layer in order to confirm the stratigraphy in the basin.

[Additional survey and report details are provided further below, and the full report is also available for download on the Company's website at http://www.AmeriLithium.com.]

Matthew Worrall, AmeriLithium’s CEO, commented: “With the results from the Jackson Wash CSAMT survey in hand, we now have all of the required data to put together what we believe will be an effective drill program for all four of our Nevada properties. Over the coming weeks we’ll be utilizing the data from those recent reports and the data received from the previous drilling to advance our exploration for commercial lithium-bearing brine concentrations in Nevada.”

ADDITIONAL SURVEY & REPORT DETAILS

The Jackson Wash CSAMT survey began on December 5th 2011, along two east-west oriented lines with total length of 10.8 kilometers (~6.71 miles) that traverse the basin’s center (as identified from the results of a previously completed gravity survey). Once the data from the survey was received, AmeriLithium’s consulting geophysicist, Mr. Jim Wright of J.L. Wright Geophysics, completed the corresponding 2nd stage report.

Of significance is the presence of a low-resistivity layer approximately 250 to 400 meters thick lying between 500 and 750 meters below the surface. This layer dips about 15 degrees to the east and is apparently present across the entire Jackson Wash property. This orientation indicates that surface and groundwater enter the basin from the Montezuma Range to the west. Montezuma Peak, in the center of the Range, is composed of volcanic rocks that have been postulated to be the source of the large lithium-brine deposits in nearby Clayton Valley. The layer is persistent horizontally to the east for nearly 5 kilometers. Near the west boundary of the property, this layer is apparently cut by an inter-basin fault. Groundwater appears to have accumulated against this barrier, evidenced by the apparent thickening of the high-conductance layer in the area.

In addition, a 200-meter thick high-conductance layer is present at a shallower depth (350 meters) in the center of the basin. This unit is essentially flat-lying and extends horizontally for about 600 meters west from the point at which this layer intersects an inter-basin fault. CSAMT data suggests that groundwater has accumulated against this fault barrier.

Again, while the presence of low resistivity in sedimentary layers within the Jackson Wash Basin and their proximity to inter-basin faults is highly suggestive of brine aquifers, it does not guarantee the presence of economic lithium-bearing brine concentrations. Rather, the only true test for economic concentrations of lithium is drilling, groundwater sampling, and laboratory analysis, which comprise the next step in the Company’s exploration process.

FOR MORE INFORMATION
More information on the Jackson Wash Project, and additional information regarding the Company, can be found at AmeriLithium’s corporate website www.amerilithium.com along with the facility to sign up for regular news updates.

ABOUT LITHIUM: Lithium is a lightweight metal used in a wide range of consumer products the world over: the medical industry uses Lithium as an anti-depressant; industrial uses include glass, ceramic and porcelain enamel manufacture; the aviation industry uses Lithium in alloys. Of particular interest is the use of Lithium for battery production, which has expanded significantly in recent years due to rechargeable Lithium batteries being used increasingly in electrical tools and in the rapidly expanding portable electronics market. Furthermore, the next generation of hybrid and electric vehicles are being designed to use high-capacity Lithium-ion batteries as environmentally-friendly fuel alternatives while the Obama administration has introduced $5 billion in funding and incentives for the development of a secure, domestic battery industry with special focus on Lithium-ion batteries.

ABOUT AMERILITHIUM: AmeriLithium is a publicly traded (NASD OTC BB: AMEL), mining company committed to progressively developing into one of the leading American players in the global Lithium industry. The Company is headquartered in Henderson, NV. AmeriLithium has amassed a Lithium portfolio consisting of ~727,319 acres, including four Nevada-based projects nearby the only Lithium producing plant in the US, a large project in Alberta, Canada, and a project in Western Australia.

ON BEHALF OF THE BOARD OF DIRECTORS,

AmeriLithium Corp.
Matthew Worrall, Chief Executive Officer

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact:
AmeriLithium Corp
871 Coronado Center Dr.
Ste. 200
Henderson
Nevada
89052

Phone: (702) 583-7790
Fax: (702) 583-7791
Email: info@amerilithium.com
Facebook: www.facebook.com/AmeriLithium
Twitter: www.twitter.com/amerilithium
Web: www.AmeriLithium.com

INVESTOR RELATIONS:
Toll Free: 1-888-982-6374
Email: ir@amerilithium.com

SOURCE AmeriLithium Corp.

Roy Warren, CEO of Attitude Drinks, commented, “Our distribution agreement with a distribution company carrying such a great reputation in customer service and follow through shows a positive beginning to our relationship with Walgreen’s. JJ Taylor Distributing Florida Inc. is a perfect example of the kind of relationship that will help us achieve our selling objectives.”

Jack Shea, Executive Vice President Sales, said: “We are delighted to be working with such a strong distributor as J.J. Taylor in Florida. The recent authorization of Phase III® Recovery in Walgreens requires an efficient sales and distribution organization to the stores. J.J. Taylor certainly fits that description.

About Attitude Drinks:

Attitude Drinks Inc. is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III® is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms as well as online. For more information, including recent clinical trial results, visit www.attitudedrinks.com.

About JJ Taylor Distributing Florida Inc.

J.J. Taylor Distributing Florida, Inc. distributes beverages in 17 counties in Florida to over 10,000 accounts. Through sales centers located in Tampa, Ft. Pierce and Ft. Myers, J.J. Taylor handles over 850 brands from 85 beverage suppliers. Learn more about J.J. Taylor at www.JJtaylor.com.

This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties the forward-looking events referred to in this release might not occur.

Contact:

Roy Warren, CEO
Attitude Drinks, Inc.
561.227.2727
roy@attitudedrinks.com
www.attitudedrinks.com

SOURCE Attitude Drinks Inc.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Sino Payments, Inc. (www.sinopayments.com)

Sino Payments is a US public company with offices in Hong Kong. Sino Payments focuses on providing IP credit and debit card processing services to large retail chains, including supermarket chains and large regional multinational retailers, in China and throughout Asia. Sino Payments has agreed with TAP to merger TAP operations and financials into Sino Payments with an expected merger close and full consolidation as of March 1, 2012.

This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties the forward-looking events referred to in this release might not occur.

Contacts:
Sino Payments, Inc.
Matthew Mecke
Chairman & CEO
T 1.877.205.6270 x801
ir@sinopayments.com

Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
info@smallcapvoice.com

SOURCE SmallCapVoice.com